1-2 of 2
Ann Maria
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

V211D Mutation in MEK1 Causes Resistance to MEK Inhibitors in Colon Cancer

Yijun Gao, Ann Maria, Na Na, Arnaud da Cruz Paula, Alexander N. Gorelick, Jaclyn F. Hechtman, Julianne Carson, Robert A. Lefkowitz, Britta Weigelt, Barry S. Taylor, HuiYong Zhao, Jorge S. Reis-Filho, Elisa de Stanchina, Neal Rosen, Zhan Yao, Rona Yaeger
Journal: Cancer Discovery
Cancer Discov (2019) 9 (9): 1182–1191.
https://doi.org/10.1158/2159-8290.CD-19-0356
Published: 03 September 2019
View articletitled, V211D Mutation in MEK1 Causes Resistance to MEK Inhibitors in Colon Cancer
Open the PDF for V211D Mutation in MEK1 Causes Resistance to MEK Inhibitors in Colon Cancer in another window
Includes: Supplementary data
Journal Articles

A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer

Joseph Vijai, Sabine Topka, Danylo Villano, Vignesh Ravichandran, Kara N. Maxwell, Ann Maria, Tinu Thomas, Pragna Gaddam, Anne Lincoln, Sarah Kazzaz, Brandon Wenz, Shai Carmi, Kasmintan A. Schrader, Steven N. Hart, Steve M. Lipkin, Susan L. Neuhausen, Michael F. Walsh, Liying Zhang, Flavio Lejbkowicz, Hedy Rennert, Zsofia K. Stadler, Mark Robson, Jeffrey N. Weitzel, Susan Domchek, Mark J. Daly, Fergus J. Couch, Katherine L. Nathanson, Larry Norton, Gad Rennert, Kenneth Offit
Journal: Cancer Discovery
Series: Author Choice
Cancer Discov (2016) 6 (11): 1267–1275.
https://doi.org/10.1158/2159-8290.CD-16-0487
Published: 01 November 2016
View articletitled, A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer
Open the PDF for A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer in another window
Includes: Supplementary data